APOB and myocardial infarction: In a prospective cohort of 96,126 adults with no prior stroke or coronary or peripheral artery disease and not receiving lipid-lowering therapy, myocardial infarction (MI) risk was independently linked to the total particle count of ApoB-containing lipoproteins but not to their size or class [8].